NVO - Novo Nordisk A/S Stock Price and Quote

NVO [NYSE]

Healthcare | Drug Manufacturers - General | Denmark

Index	-	P/E	41.07	EPS (ttm)	3.39	Insider Own	26.40%	Shs Outstand	2.26B	Perf Week	-1.43%
Market Cap	241.89B	Forward P/E	35.47	EPS next Y	3.92	Insider Trans	0.00%	Shs Float	1.21B	Perf Month	4.13%
Income	7.74B	PEG	21.06	EPS next Q	0.86	Inst Own	8.40%	Short Float / Ratio	0.14% / 1.17	Perf Quarter	30.44%
Sales	24.49B	P/S	9.88	EPS this Y	15.20%	Inst Trans	-5.21%	Short Interest	1.65M	Perf Half Y	19.82%
Book/sh	4.97	P/B	27.98	EPS next Y	20.20%	ROA	24.80%	Target Price	139.83	Perf Year	45.70%
Cash/sh	3.16	P/C	44.07	EPS next 5Y	1.95%	ROE	73.30%	52W Range	94.75 - 144.78	Perf YTD	2.75%
Dividend	1.60	P/FCF	48.25	EPS past 5Y	6.70%	ROI	48.60%	52W High	-3.95%	Beta	0.50
Dividend %	1.15%	Quick Ratio	0.70	Sales past 5Y	4.70%	Gross Margin	84.20%	52W Low	46.77%	ATR	2.48
Employees	52696	Current Ratio	0.90	Sales Q/Q	27.90%	Oper. Margin	42.70%	RSI (14)	60.64	Volatility	2.00% 1.55%
Optionable	Yes	Debt/Eq	0.34	EPS Q/Q	20.40%	Profit Margin	31.60%	Rel Volume	1.03	Prev Close	138.09
Shortable	Yes	LT Debt/Eq	0.31	Earnings	Nov 02 BMO	Payout	319.40%	Avg Volume	1.40M	Price	139.06
Recom	1.30	SMA20	1.19%	SMA50	6.70%	SMA200	22.09%	Volume	1,444,243	Change	0.70%

Jul-15-22

Upgrade

Morgan Stanley

Equal-Weight → Overweight

Jun-28-22

Downgrade

UBS

Neutral → Sell

Jun-27-22

Upgrade

Exane BNP Paribas

Underperform → Neutral

Jun-07-22

Upgrade

JP Morgan

Neutral → Overweight

May-31-22

Upgrade

Guggenheim

Neutral → Buy

Apr-25-22

Upgrade

Cowen

Market Perform → Outperform

$130

Apr-12-22

Upgrade

Morgan Stanley

Underweight → Equal-Weight

Mar-16-22

Upgrade

Deutsche Bank

Hold → Buy

Jan-25-22

Downgrade

Liberum

Hold → Sell

Dec-20-21

Downgrade

JP Morgan

Overweight → Neutral

Show Previous Ratings

Jan-30-23 04:58PM	U.S. Appeals Court Sides With Drugmakers on Discount Program The Wall Street Journal
03:27PM	UPDATE 1-Drugmakers prevail in dispute over U.S. discount drug program Reuters
12:53PM	Drugmakers prevail in dispute over U.S. discount drug program Reuters
12:42PM	Drugmakers prevail in dispute over U.S. discount drug program Reuters
10:11AM	Eli Lilly (LLY) Lymphoma Candidate Pirtobrutinib Gets FDA Nod Zacks
08:05AM	Loading…
08:05AM	Merck (MRK) to Report Q4 Earnings: What's in the Cards? Zacks
05:11AM	Beat the Market the Zacks Way: NVIDIA, Bilibili, Novo Nordisk in Focus Zacks
Jan-27-23 09:36AM	Weibo and Viasat have been highlighted as Zacks Bull and Bear of the Day Zacks
08:23AM	Eli Lilly (LLY) to Report Q4 Earnings: What's in the Cards? Zacks
Jan-26-23 06:18PM	How Did COVID Reshape the Labor Markets Zacks
10:20AM	Is a Beat on the Cards for Novo Nordisk (NVO) in Q4 Earnings? Zacks
09:53AM	2 Market-Beating Stocks to Buy in 2023 and Hold for 10 Years Motley Fool
07:53AM	Can Pfizer (PFE) Beat Expectations This Earnings Season? Zacks
06:53AM	Dow, IBM, and SAP Keep the Layoffs Coming. Its Spreading Beyond Tech. Barrons.com
Jan-25-23 09:00AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar Zacks
02:56AM	Loading…
02:56AM	Eli Lilly, Novo Nordisk Get a Share-Price Pop From Weight-Loss Drugs Barrons.com
Jan-24-23 12:27PM	Novartis' (NVS) Unit to Acquire Astellas' Rights of Mycamine Zacks
Jan-23-23 05:45PM	Novo Nordisk (NVO) Stock Sinks As Market Gains: What You Should Know Zacks
06:42AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Jan-20-23 12:45PM	3 Reasons Growth Investors Will Love Novo Nordisk (NVO) Zacks
08:30AM	Here's How Much a $1000 Investment in Novo Nordisk Made 10 Years Ago Would Be Worth Today Zacks
08:05AM	J&J (JNJ) to Begin Q4 Earnings Season for Pharma Sector Zacks
Jan-17-23 05:50PM	Novo Nordisk (NVO) Gains As Market Dips: What You Should Know Zacks
07:33AM	Zacks.com featured highlights include Oxford Industries, Ingredion, Novo Nordisk, Helmerich & Payne and Fox Factory Holdings Zacks
Jan-16-23 11:40AM	SNY vs. NVO: Which Stock Is the Better Value Option? Zacks
09:25AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
08:01AM	Bet on These 5 Low Leverage Stocks Amid Easing Inflation Zacks
07:28AM	Beat the Market the Zacks Way: Oracle, NVIDIA, Kimberly-Clark in Focus Zacks
Jan-13-23 04:03PM	How Novo Nordisk Just Expanded Its Diabetes Lead Over Pfizer, Eli Lilly Investor's Business Daily
11:39AM	State of California Sues Insulin Makers for Unfair Practices Zacks
09:30AM	Loading…
09:30AM	Wall Street Bulls Look Optimistic About Novo Nordisk (NVO): Should You Buy? Zacks
07:18AM	Do You Think Novo Nordisk A/S (NVO) is an Economically Sensitive Stock? Insider Monkey
06:00AM	Biz: One lot could become two homes in Raleigh; Bakatsias opens new restaurant American City Business Journals
Jan-12-23 05:22PM	California is latest state to sue drug companies over high insulin prices MarketWatch
04:01PM	EXL Announces Appointment of Andreas Fibig to Board of Directors GlobeNewswire
09:56AM	Aprea (APRE) Rises on Advancing Lead Drug to Clinical Studies Zacks
Jan-11-23 07:14PM	Amarin's (AMRN) Q4 Preliminary Revenues Top Expectations Zacks
02:09PM	Durham Tech using $6M gift from Novo Nordisk to build life sciences training center American City Business Journals
Jan-10-23 03:19PM	Analyst Report: Novo Nordisk A/S Morningstar Research
12:43PM	2 Top Biotech Stocks Defying the Bear Market Motley Fool
08:29AM	AstraZeneca (AZN) Set to Acquire CinCor Pharma for $1.3B Zacks
Jan-09-23 05:50PM	Novo Nordisk (NVO) Dips More Than Broader Markets: What You Should Know Zacks
04:08PM	U.S. experts recommend weight-loss drugs for obese children Reuters
01:35PM	Why You Should Hold Elevance Health (ELV) in Your Portfolio Zacks
10:37AM	FDA Accepts Pfizer's (PFE) sBLA Filing for Pneumococcal Jab Zacks
10:16AM	Novo Nordisk A/S - share repurchase programme GlobeNewswire
Jan-07-23 07:00AM	This Pharma Presents a Potential 'Lose-Win' Situation for Patients and Investors TheStreet.com
07:00AM	If You Lose (Weight), Then This Pharma Could Gain Big TheStreet.com
Jan-06-23 11:50AM	HCA Healthcare (HCA) Rises 43% in 6 Months: More Room to Run? Zacks
09:40AM	Is Novo Nordisk (NVO) Stock Outpacing Its Medical Peers This Year? Zacks
09:34AM	10 Biggest Biotechnology Companies Investopedia
04:35AM	The Zacks Analyst Blog Highlights Alphabet, Adobe, TotalEnergies, Novo Nordisk and Diageo Zacks
Jan-05-23 01:48PM	Top Analyst Reports for Alphabet, Novo Nordisk & TotalEnergies Zacks
12:00PM	Novo Nordisk (NVO) Upgraded to Strong Buy: Here's Why Zacks
10:00AM	Best Momentum Stock to Buy for January 5th Zacks
08:28AM	New Strong Buy Stocks for January 5th Zacks
Jan-04-23 12:45PM	Here is Why Growth Investors Should Buy Novo Nordisk (NVO) Now Zacks
12:00PM	What Makes Novo Nordisk (NVO) a Strong Momentum Stock: Buy Now? Zacks
08:30AM	Here's How Much You'd Have If You Invested $1000 in Novo Nordisk a Decade Ago Zacks
05:20AM	How TikTok Could Help This Healthcare Stock Take Off Motley Fool
Jan-03-23 06:32AM	Beat the Market Like Zacks: JPMorgan Chase, Oracle, BioVie in Focus Zacks
Dec-31-22 05:52PM	Jim Simons Stock Portfolio: 10 Biggest Healthcare Stocks Insider Monkey
Dec-28-22 12:00AM	Race is on to develop new generation of weight-loss drugs Financial Times
Dec-24-22 11:00AM	2 Market-Beating Stocks to Buy in 2023 and Hold Forever Motley Fool
Dec-23-22 09:18AM	The Zacks Analyst Blog Highlights Novo Nordisk, AstraZeneca, Accenture, Chubb and Roper Technologies Zacks
Dec-22-22 02:31PM	Top Research Reports for Novo Nordisk, AstraZeneca & Accenture Zacks
08:13AM	Novo Nordisk A/S: GlobeNewswire
Dec-21-22 03:55PM	12 Most Advanced Countries in Biotechnology Insider Monkey
Dec-19-22 12:55PM	7 Hot Stocks to Book Profits In Before 2023 InvestorPlace
11:15AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
06:39AM	Beat the Market Like Zacks: Vivint, Caterpillar, Oracle in Focus Zacks
Dec-15-22 05:00AM	Zacks Investment Ideas feature highlights: Novo Nordisk Zacks
05:00AM	Zacks Industry Outlook Highlights Johnson & Johnson, Novo Nordisk, Merck and AstraZeneca Zacks
Dec-14-22 12:30PM	Simplify Your Investing Process Using This Top-Down Approach Zacks
08:34AM	4 Large Drug Stocks to Watch in a Booming Industry Zacks
08:30AM	2 Stocks That Could Be Red-Hot Buys in 2023 Motley Fool
Dec-13-22 04:14PM	The Bullish Call Eli Lilly Made For Its Next-Gen Obesity Drug, A Rival To Novo, Amgen Investor's Business Daily
11:39AM	22 Most Charitable Companies in 2022 Insider Monkey
07:43AM	After US Launch Bottlenecks, Novo Nordisk Pushes European Rollout For Wegovy In 2023 Benzinga
Dec-12-22 10:26AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Dec-09-22 05:42PM	Our 7 Top Biotech Stock Picks for 2023 InvestorPlace
04:10PM	How An Eli Lilly Decision Could Light Up The Red-Hot Obesity Landscape Again Investor's Business Daily
Dec-08-22 01:48PM	Here's What We Know So Far About Amgen's Obesity Drug As It Trails Novo Nordisk, Eli Lilly Investor's Business Daily
Dec-05-22 08:04AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
07:19AM	Beat the Market Like Zacks: Novo Nordisk, Axon, General Mills in Focus Zacks
Dec-04-22 06:00AM	Why You Cant Find Wegovy, the Weight-Loss Drug The Wall Street Journal
Dec-02-22 12:43PM	Rigel (RIGL) Up on FDA Nod to Blood Cancer Drug Rezlidhia Zacks
Dec-01-22 04:14PM	Amgen Is The Underdog In Obesity Treatment But It's Creeping Up On Novo Nordisk, Eli Lilly Investor's Business Daily
Nov-30-22 01:05PM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
11:30AM	Novo Nordisk Stock Flashing Renewed Technical Strength Investor's Business Daily
Nov-29-22 11:25AM	Novo Nordisk Earns 92 RS Rating, Showing Market Leadership Investor's Business Daily
Nov-27-22 05:27PM	11 Best Diabetes Stocks To Buy Now Insider Monkey
Nov-24-22 10:51AM	Should You Invest in Novo Nordisk A/S (NVO) Stock? Insider Monkey
08:37AM	3 Healthcare Stocks That Could Set You Up For Life Motley Fool
Nov-23-22 09:36AM	15 Biggest European Pharmaceutical Companies Insider Monkey
Nov-22-22 10:07AM	Prothena (PRTA) Earns Milestone Payment From Novo Nordisk Zacks
09:48AM	Novo Nordisk To Invest Over DKK5B To Add API Production Capacity To Danish Plant Benzinga
01:48AM	UPDATE 2-Drug maker Novo Nordisk invests $744 mln to expand Danish plant Reuters
12:58AM	Drug maker Novo Nordisk invests $744 million to expand Danish plant Reuters
12:31AM	Novo Nordisk invests DKK 5.4 bn Danish kroner in expansion of clinical manufacturing facilities in Bagsværd, Denmark GlobeNewswire

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience